Alexandria, Virginia - April 24, 2017 - Biologics Consulting, a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices, announced today that its Chemistry, Manufacturing, and Controls (CMC) Specialty Group advised BriaCell Therapeutics Corp. (TSXV: BCT) (OCTCQB: BCTXF), a clinical-stage company dedicated to the development of immuno-oncology treatments, in the preparation and filing of a CMC amendment detailing the extensive testing performed on BriaVax™, the company’s proprietary vaccine for advanced breast cancer. Following its review of the amendment, the FDA granted BriaCell authorization to initiate its Phase I/IIa clinical trial.
Seattle - January 5, 2017 - IDRI is expanding its Board of Directors, comprised of international leaders in industry and academia, with the recent addition of Norman Baylor, Ph.D., who has extensive experience in the field of vaccines and vaccine-related products, including 20 years with the Food and Drug Administration (FDA).
Alexandria, Virginia - January 4, 2017 - Biologics Consulting announced today that it is opening a new office in the center of Maryland's Technology Corridor and Life Sciences Hub.
Alexandria, Virginia - August 16, 2016 - Biologics Consulting announced today the addition of three new consultants, further increasing the company's capacity to deliver comprehensive scientific, technical and strategic guidance to clients in any stage of the regulatory approval and product development processes.
Alexandria, VA - April 19, 2016 - Biologics Consulting announces the launch of its Clinical Trials Planning and Oversight Group.
Alexandria, VA - January 19, 2016 - Biologics Consulting has launched a rebranding effort that includes the introduction of new brand positioning, as well as a new logo and interactive website.